Search PDMR transactions

Notifier
Name
Next Stage Ventures ApS
Reason for notification
Closely associated
Yes
Person discharging managerial responsibilities
Henrik Stage
Position
CFO of SynAct Pharma AB
Initial notification
Yes
Amendment
No
Details of amendment
Issuer
Name of issuer
SynAct Pharma
LEI code
549300RRYIEFEQ72N546
Details of transaction
Financial instrument ISIN code Nature of transaction Linked to a share option programme Volume Unit Price Currency code Transaction date Trading venue
Purchase of Synact Pharma AB Shares SE0008241491 Acquisition 7,000 Quantity 6.89480714 SEK 03/10/2017 AKTIETORGET
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Trading venue Volume Weighted average price
Purchase of Synact Pharma AB Shares SE0008241491 Acquisition 03/10/2017 AKTIETORGET 7,000 (Quantity) 6.89480714 SEK
Total: 7,000
<< Back